RIM Analyst Expects Dip and 4 Stock Analyses to Know Now
Halliburton Company (NYSE:HAL): Current Price: $40.17
After Halliburton reported stronger 2013 results than predicted and stated that it thinks that North American margins have bottomed, RBC Capital predicts that Halliburton’s North American margins will rebound throughout the year. The firm keeps its Outperform rating on the stock.
Hologic Inc. (NASDAQ:HOLX): Current Price: $23.64
After the firm conducted checks with radiologists, RBC Capital believes that the radiologists were “very impressed” with the results of a study of Hologic’s Tomo product. The firm predicts that nearly 800 Tomo units will be installed by the end of Hologic’s FY13, which is towards the upper end of the company’s implied guidance, according to RBC Capital. The firm keeps a Top Pick rating but increases its price targets to $26 from $23 on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Current Price: $45.67
RBC Capital recommends purchasing Vertex shares on pullback due to its belief that the stock has the potential to move towards $80+ on positive Phase III CF combo data during 1H14. The firm keeps its Outperform rating and a $70 price target on the stock.
PennyMac Mortgage Investment Trust (NYSE:PMT): Current Price: $26.60
PennyMac has been removed from Citigroup’s Top Picks Live list due to the rally in shares along with recent compression of mortgage spreads. Citi reiterates its Buy rating and a $30 price target on the stock.
Research In Motion Limited (NASDAQ:RIMM): Current Price: $17.23
RBC Capital predicts a drop in Research in Motion’s stock following the company’s launch of its new BB10 operating system and devices, as many details about the device have already been leaked. The firm predicts that RIM will sell 10 million BB10 units during the year but is less bullish on the company’s margins. The firm keeps its Sector Perform rating on the stock.